Streetbeat News

Stock Prices

ZBH

Zimmer Biomet Holdings, Inc. reported better-than-expected Q3 earnings with adjusted EPS of $1.74 and sales of $1.82 billion, beating consensus estimates. The company updated its 2024 guidance, slightly lowering EPS expectations and revenue growth forecasts. Despite ERP challenges, Zimmer Biomet plans to launch the Z1 Femoral Hip System in 2024.

Portfolio Pulse from Vandana Singh

October 30, 2024 | 4:04 pm

CHE

Chemed's shares declined following the release of disappointing Q3 financial results and lower-than-expected FY24 EPS guidance.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 4:02 pm

ATGE

Adlatem Global Education shares rose after the company increased its FY24 guidance. Barrington Research and BMO Capital also raised their price targets for the stock.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 4:01 pm

VST

Vistra (NYSE:VST) has significantly outperformed the market over the past 5 years, with an annualized return of 36.84%. A $100 investment in Vistra 5 years ago would now be worth $462.10. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

October 30, 2024 | 4:00 pm

FCNCA

First Citizens BancShares (NASDAQ:FCNCA) has significantly outperformed the market over the past decade, with an average annual return of 22.95%. A $100 investment in FCNCA 10 years ago would now be worth $784.81, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 30, 2024 | 4:00 pm

DRS

Leonardo DRS shares rose following the company's announcement of better-than-expected Q3 financial results and an increase in its FY24 guidance.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 3:59 pm

BLKB

Blackbaud shares declined following the release of disappointing Q3 financial results and a reduction in FY24 guidance.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 3:57 pm

OPCH

Option Care Health shares are trading lower following the company's Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 3:56 pm

CRTO

Criteo's shares have declined following the release of disappointing Q3 revenue results.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 3:56 pm

COIN

Coinbase Glb (NASDAQ:COIN) has seen unusual options activity, with a mix of bullish and bearish trades. The options scanner detected 58 uncommon trades, with a significant amount of money involved. The sentiment is split, with 31% bullish and 41% bearish. Analysts have mixed ratings, with price targets ranging from $175 to $320. The stock is currently down 0.52% at $218.51, and RSI indicators suggest it may be overbought.

Portfolio Pulse from Benzinga Insights

October 30, 2024 | 3:46 pm